Drug to treat canine lymphoma gets FDA approvalJanuary 3, 2017VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
SPONSORED CONTENTHill's Prescription Diet Metabolic Weight + j/dNutrition to help mobility in as little as 1 month. 88% of pets lost weight in 2 months at home with Metabolic nutrition. + Learn More